In one institution, a weekly multidisciplinary meeting has proved to improve care for patients with cancer who are receving concurrent therapies.
Multidisciplinary teams can improve care in patients with cancer who are receiving concurrent therapy, explained Dorothy Abshire, BSN, BA, RN, OCN.
Abshire, a nurse at Baylor Scott and White McClinton Cancer Center, comprised a multidisciplinary team of infusion nurses, chemotherapy nurses, physicians, and others, to meet each week and discuss all patients who have concurrent therapy. This helps to ensure that appointments are made, patients are getting their treatments on time, and that their lab work appointments are also being made and met appropriately.
Survival Benefit, Durable Responses Continue at 3 Years With Liso-cel in Second-line LBCL
July 15th 2024Three-year findings from the TRANSFORM trial provide further evidence that liso-cel should be considered as the new standard of care along with other CAR T-cell therapies for patients with primary refractory or relapsed LBCL, an expert said.